Jantien P Brouwer

Summary

Affiliation: Academic Medical Center
Country: The Netherlands

Publications

  1. ncbi Thyroid and adrenal axis in major depression: a controlled study in outpatients
    Jantien P Brouwer
    Department of Endocrinology, University of Amsterdam, Amsterdam, The Netherlands
    Eur J Endocrinol 152:185-91. 2005
  2. ncbi Thyrotropin, but not a polymorphism in type II deiodinase, predicts response to paroxetine in major depression
    Jantien P Brouwer
    Department of Endocrinology, Academic Medical Center, The Netherlands
    Eur J Endocrinol 154:819-25. 2006
  3. ncbi Prediction of treatment response by HPA-axis and glucocorticoid receptor polymorphisms in major depression
    Jantien P Brouwer
    Department of Endocrinology, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, Netherlands
    Psychoneuroendocrinology 31:1154-63. 2006
  4. ncbi Triiodothyronine addition to paroxetine in the treatment of major depressive disorder
    Bente C Appelhof
    Department of Endocrinology and Metabolism, Academic Medical Center, University of Amsterdam, 1100 DE Amsterdam, The Netherlands
    J Clin Endocrinol Metab 89:6271-6. 2004
  5. ncbi Longitudinal assessment of serum anticholinergic activity in delirium of the elderly
    Barbara C van Munster
    Department of Medicine, Academic Medical Centre, University of Amsterdam, PO Box 22660, 1100 DD Amsterdam, The Netherlands
    J Psychiatr Res 46:1339-45. 2012
  6. ncbi Glucocorticoids and relapse of major depression (dexamethasone/corticotropin-releasing hormone test in relation to relapse of major depression)
    Bente C Appelhof
    Department of Endocrinology and Metabolism, Academic Medical Center of the University of Amsterdam, The Netherlands
    Biol Psychiatry 59:696-701. 2006

Detail Information

Publications6

  1. ncbi Thyroid and adrenal axis in major depression: a controlled study in outpatients
    Jantien P Brouwer
    Department of Endocrinology, University of Amsterdam, Amsterdam, The Netherlands
    Eur J Endocrinol 152:185-91. 2005
    ..We therefore conducted a controlled study in unipolar depressed outpatients who had been free of antidepressants for at least 3 months...
  2. ncbi Thyrotropin, but not a polymorphism in type II deiodinase, predicts response to paroxetine in major depression
    Jantien P Brouwer
    Department of Endocrinology, Academic Medical Center, The Netherlands
    Eur J Endocrinol 154:819-25. 2006
    ....
  3. ncbi Prediction of treatment response by HPA-axis and glucocorticoid receptor polymorphisms in major depression
    Jantien P Brouwer
    Department of Endocrinology, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, Netherlands
    Psychoneuroendocrinology 31:1154-63. 2006
    ..We investigated whether treatment response is predicted by hypothalamus-pituitary-adrenal (HPA) axis parameters, or by genetic polymorphisms in the glucocorticoid receptor (GR), that regulates its feedback...
  4. ncbi Triiodothyronine addition to paroxetine in the treatment of major depressive disorder
    Bente C Appelhof
    Department of Endocrinology and Metabolism, Academic Medical Center, University of Amsterdam, 1100 DE Amsterdam, The Netherlands
    J Clin Endocrinol Metab 89:6271-6. 2004
    ..On the contrary, more adverse reactions occurred in T3-treated patients...
  5. ncbi Longitudinal assessment of serum anticholinergic activity in delirium of the elderly
    Barbara C van Munster
    Department of Medicine, Academic Medical Centre, University of Amsterdam, PO Box 22660, 1100 DD Amsterdam, The Netherlands
    J Psychiatr Res 46:1339-45. 2012
    ..We assessed the association of serum anticholinergic activity with delirium and its risk factors in a longitudinal study on elderly hip fracture patients...
  6. ncbi Glucocorticoids and relapse of major depression (dexamethasone/corticotropin-releasing hormone test in relation to relapse of major depression)
    Bente C Appelhof
    Department of Endocrinology and Metabolism, Academic Medical Center of the University of Amsterdam, The Netherlands
    Biol Psychiatry 59:696-701. 2006
    ..Knowledge of pathogenic mechanisms and predictors of relapse in major depressive disorder is still limited. Hypothalamic-pituitary-adrenocortical (HPA) axis dysregulation is thought to be related to the development and course of depression...